title: Can prognostic factors be used to direct therapy in chronic lymphocytic leukemia?
abstract: Chronic lymphocytic leukemia (CLL) shows a heterogeneous clinical course, which can be explained in part by prognostic factors. Most patients do not need treatment at the time of first diagnosis. The identification of prognostic factors is of major interest if strategies can be devised to treat patients according to their individual risk profile or biological subgroup. Currently, in spite of a wealth of prognostic factors, individualized treatment approaches in different genetic or risk groups are the exemption in CLL. This review summarizes the most important prognostic and predictive factors in CLL, with particular emphasis on factors affecting treatment decisions in clinical trials and routine practice.
authors.affiliation: Department of Medicine V, University Hospital Heidelberg, Im Neuenheimer Feld 410, Heidelberg, Germany.
authors.forename: Leopold
authors.initials: L
authors.lastname: Sellner
authors.forename: Sascha
authors.initials: S
authors.lastname: Dietrich
authors.forename: Peter
authors.initials: P
authors.lastname: Dreger
authors.forename: Hanno
authors.initials: H
authors.lastname: Glimm
authors.forename: Thorsten
authors.initials: T
authors.lastname: Zenz
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000032:analysis*; D006801:Humans; D060828:Induction Chemotherapy / Q000379:methods; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000175:diagnosis / Q000235:genetics / Q000276:immunology / Q000628:therapy*; D009154:Mutation; D010641:Phenotype; D011237:Predictive Value of Tests; D011379:Prognosis; D018570:Risk Assessment; D012307:Risk Factors; D033581:Stem Cell Transplantation; D013997:Time Factors
chemical_list: D014408:Biomarkers, Tumor